Decreased T2 signal in the thalami may be a sign of lysosomal storage disease

Neuroradiology

Volumn 49, Issue 7, 2007, Pages 571-578

  Autti, Taina ^a   Joensuu, Raimo ^b   Åberg, Laura ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b ASTRAZENECA R AND D   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Brain; Lysosomal storage disease; MRI; Thalamus

Indexed keywords

ALPHA LEVO FUCOSIDASE; BETA GALACTOSIDASE; BETA N ACETYLHEXOSAMINIDASE A; CEREBROSIDE SULFATASE; CERULOPLASMIN; MANNOSIDASE; N ACETYLGALACTOSAMINE 6 SULFATASE; PALMITOYL PROTEIN THIOESTERASE; SIALIDASE;

ASPARTYLGLYCOSAMINURIA; CERULOPLASMIN DEFICIENCY; DIAGNOSTIC VALUE; ENZYME DEFICIENCY; FUCOSIDOSIS; GLOBOID CELL LEUKODYSTROPHY; GM1 GANGLIOSIDOSIS; GM2 GANGLIOSIDOSIS; HUMAN; LYSOSOME STORAGE DISEASE; MANNOSIDOSIS; MEDLINE; MORQUIO SYNDROME; NEURONAL CEROID LIPOFUSCINOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; THALAMUS;

HUMANS; LYSOSOMAL STORAGE DISEASES, NERVOUS SYSTEM; MAGNETIC RESONANCE IMAGING; THALAMUS;

EID: 34447100391     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-007-0220-6     Document Type: Review

References (121)

1. Agamanolis D (2005) Metabolic and toxic disorders. In: Prayson R, Goldblum J (eds) Neuropathology. Elsevier Churchill Livingstone, Philadelphia, pp 339-372
2. Pastores GM, Kolodny EH (2006) Lysosomal storage diseases. In: Swaiman KF, Ashwall S, Ferriero DM (eds) Pediatric neurology: Principles and practice. Mosby Elsevier, Philadelphia, pp 659-714
3. Autti T, Raininko R, Vanhanen S-L, Kallio M, Santavuori P (1994) MRI of the normal brain from early childhood to middle age. I Appearances on T2- and proton density-weighted images and occurrence of incidental high-signal foci. Neuroradiology 36:644-648
4. Autti T, Raininko R, Vanhanen S-L, Kallio M, Santavuori P (1994) MRI of the normal brain from early childhood to middle age. II. Age dependence of signal intensity changes on T2-weighted images. Neuroradiology 36:649-651
5. Barkovich AJ (ed) (2005) Pediatric neuroimaging. Lippincott Williams & Wilkins, Philadelphia, pp 76-189
6. Morita H, Ikeda S, Yamamoto K et al (1995) Hereditary ceruloplasmin deficiency with hemosiderosis: A clinicopathological study of a Japanese family. Ann Neurol 37:646-656
7. Hatanaka Y, Okano T, Oda K, Yamamoto K, Yoshida K (2003) Aceruloplasminemia with juvenile-onset diabetes mellitus caused by exon skipping in the ceruloplasmin gene. Intern Med 42:599-604
8. Yonekawa M, Okabe T, Asamoto Y, Ohta M (1998) A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh-frozen human plasma. Eur Neurol 42:157-162
9. Al-Essa MA, Bakheet SM, Patay ZJ, Nounou RM, Ozand PT (1999) Cerebral fuorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI, and clinical observations in a patient with infantile G(M1) gangliosidosis. Brain Dev 21:559-562
10. Chen CY, Zimmerman RA, Lee CC, Chen FH, Yuh YS, Hsiao HS (1998) Neuroimaging findings in late infantile GM1 gangliosidosis. AJNR Am J Neuroradiol 19:1628-1630
11. Kobayashi O, Takashima S (1994) Thalamic hyperdensity on CT in infantile GM1-gangliosidosis. Brain Dev 16:472-474
12. Aydin K, Bakir B, Tatli B, Terzibasioglu E, Ozmen M (2005) Proton MR spectroscopy in three children with Tay-Sachs disease. Pediatr Radiol 35:1081-1085
13. Grosso S, Farnetani MA, Berardi R et al (2003) GM2 gangliosidosis variant B1 neuroradiological findings. J Neurol 250:17-21
14. Mugikura S, Takahashi S, Higano S, Kurihara N, Kon K, Sakamoto K (1996) MR findings in Tay-Sachs disease. J Comput Assist Tomogr 20:551-555
15. Yun YM, Lee SN (2005) A case report of Sandhoff disease. Korean J Ophthalmol 19:68-72
16. Yuksel A, Yalcinkaya C, Islak C, Gunduz E, Seven M (1999) Neuroimaging findings of four patients with Sandhoff disease. Pediatr Neurol 21:562-565
17. Hittmair K, Wimberger D, Bernert G, Mallek R, Schindler EG (1996) MRI in a case of Sandhoff's disease. Neuroradiology 38 [Suppl 1]:S78-S80
18. Caliskan M, Ozmen M, Beck M, Apak S (1993) Thalamic hyperdensity - is it a diagnostic marker for Sandhoff disease. Brain Dev 15:387-388
19. Koelfen W, Freund M, Jaschke W, Koenig S, Schultze C (1994) GM-2 gangliosidosis (Sandhoff's disease): Two year follow-up by MRI. Neuroradiology 36:152-154
20. Zafeiriou DI, Anastasiou AL, Michelakaki EM, Augoustidou-Savvopoulou PA, Katzos GS, Kontopoulos EE (1997) Early infantile Krabbe disease: deceptively normal magnetic resonance imaging and serial neurophysiological studies. Brain Dev 19:488-491
21. Zafeiriou DI, Michelakaki EM, Anastasiou AL, Gombakis NP, Kontopoulos EE (1996) Serial MRI and neurophysiological studies in late-infantile Krabbe disease. Pediatr Neurol 15:240-244
22. Vanhanen SL, Raininko R, Santavuori P (1994) Early differential diagnosis of infantile neuronal ceroid lipofuscinosis, Rett syndrome, and Krabbe disease by CT and MR. AJNR Am J Neuroradiol 15:1443-1453
23. Bernardi B, Fonda C, Franzoni E, Marchiani V, Della Guistina E, Zimmerman RA (1994) MRI and CT in Krabbe's disease: Case report. Neuroradiology 36:477-479
24. Finelli DA, Tarr RW, Sawyer RN, Horwitz SJ (1994) Deceptively normal MR in early infantile Krabbe disease. AJNR Am J Neuroradiol 15:167-171
25. Barone R, Bruhl K, Stoeter P, Fiumara A, Pavone L, Beck M (1996) Clinical and neuroradiological findings in classic infantile and late-onset globoid-cell leukodystrophy (Krabbe disease). Am J Med Genet 63:209-217
26. Percy AK, Odrezin GT, Knowles PD, Rouah E, Armstrong DD (1994) Globoid cell leukodystrophy: Comparison of neuropathology with magnetic resonance imaging. Acta Neuropathol (Berl) 88:26-32
27. Autti T, Raininko R, Haltia M et al (1997) Aspartylglucosaminuria: radiologic course of the disease with histopathologic correlation. J Child Neurol 12:369-375
28. Ara JR, Mayayo E, Marzo ME, Guelbenzu S, Chabas A, Pina MA, Calderon C (1999) Neurological impairment in alpha-mannosidosis: A longitudinal clinical and MRI study of a brother and sister. Childs Nerv Syst 15:369-371
29. Inui K, Akagi M, Nishigaki T, Muramatsu T, Tsukamoto H, Okada S (2000) A case of chronic infantile type of fucosidosis: Clinical and magnetic resonance image findings. Brain Dev 22:47-49
30. Autti T, Raininko R, Launes J, Nuutila A, Santavuori P (1992) Jansky-Bielschowsky variant disease: CT, MRI and SPECT findings. Pediatric Neurol 8:121-126
31. Vanhanen SL, Raininko R, Autti T, Santavuori P (1996) MRI evaluation of the brain in infantile neuronal ceroid lipofuscinosis. Part 2: MRI findings in 21 patients. J Child Neurol 10:444-450
32. Autti T, Raininko R, Vanhanen SL, Santavuori P (1996) MRI of neuronal ceroid lipofuscinosis. I. Cranial MRI of 30 patients with juvenile neuronal ceroidl lipofuscinosis. Neuroradiology 38:476-782
33. Topçu M, Tan H, Yalnizoǧlu D et al (2004) Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: Clinical, neurophysiological, neuroradiological and histopathologic studies. Turk J Pediatr 46:1-10
34. Frei KP, Patronas NJ, Crutchfield KE. Altarescu G, Schiffmann R (1998) Mucolipidosis type IV: Characteristic MRI findings. Neurology 51:565-569
35. Inglese M, Nusbaum AO, Pastores GM, Gianutsos J, Kolodny EH, Gonen O (2005) MR imaging and proton spectroscopy of neural injury in late-onset GM2 gangliosidosis. AJNR Am J Neuroradiol 26:2037-2042
36. Gururaj A, Sztriha L, Hertecant, J, Johansen JG, Georgiou T, Campos Y, Drousiotou A, d'Azzo A (2005) Magnetic resonance imaging findings and novel mutations in GM1 gangliosidosis. J Child Neurol 20:57-60
37. Streifler JY, Gornish M, Hadar H, Gadoth N (1993) Brain imaging in late-onset GM2 gangliosidosis. Neurology 43:2055-2058
38. Uyama E, Terasaki T, Watanabe S, Naito M, Owada M, Araki S, Ando M (1992) Type 3 GM1 gangliosidosis: Characteristic MRI findings correlated with dystonia. Acta Neurol Scand 86:609-615
39. Fukumizu M, Yoshikawa H, Takashima S, Sakuragawa N, Kurokawa T (1992) Tay-Sachs disease: Progression of changes on neuroimaging in four cases. Neuroradiology 34:483-486
40. Seitz D, Grodd W, Schwab A, Seeger U, Klose U, Nagele T (1998) MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis. AJNR Am J Neuroradiol 19:1373-1377
41. Choi S, Enzmann DR (1993) Infantile Krabbe disease: Complementary CT and MR findings. AJNR Am J Neuroradiol 14:1164-1166
42. Chang YC, Huang CC, Chen CY, Zimmerman RA (2000) MRI in acute neuropathic Gaucher's disease. Neuroradiology 42:48-50
43. Moore DF, Ye F, Schiffmann R, Butman JA (2003) Increased signal intensity in the pulvinar on T1-weighted images: A pathognomonic MR imaging sign of Fabry disease. AJNR Am J Neuroradiol 24:1096-1101
44. Politei JM, Capizzano AA (2006) Magnetic resonance image findings in 5 young patients with Fabry disease. Neurologist 12:103-105
45. Gupta S, Ries M, Kotsopoulos S, Schiffmann R (2005) The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women. Medicine (Baltimore) 84:261-268
46. Takanashi J, Barkovich AJ, Dillon WP, Sherr EH, Hart KA, Packman S (2003) T1 hyperintensity in the pulvinar: Key imaging feature for diagnosis of Fabry disease. AJNR Am J Neuroradiol 24:916-921
47. Morse RP, Kleta R, Alroy J, Gahl WA (2005) Novel form of intermediate salla disease: Clinical and neuroimaging features. J Child Neurol 20:814-816
48. Parazzini C, Arena S, Marchetti L et al (2003) Infantile sialic acid storage disease: Serial ultrasound and magnetic resonance imaging features. AJNR Am J Neuroradiol 24:398-400
49. Linnankivi T, Lonnqvist T, Autti T (2003) A case of Salla disease with involvement of the cerebellar white matter. Neuroradiology 45:107-109
50. Sonninen P, Autti T, Varho T, Hamalainen M, Raininko R (1999) Brain involvement in Salla disease. AJNR Am J Neuroradiol 20:433-443
51. Varho T, Jaaskelainen S, Tolonen U, Sonninen P, Vainionpaa L, Aula P, Sillanpaa M (2000) Central and peripheral nervous system dysfunction in the clinical variation of Salla disease. Neurology 55:99-104
52. Haataja L, Parkkola R, Sonninen P et al (1994) Phenotypic variation and magnetic resonance imaging (MRI) in Salla disease, a free sialic acid storage disorder. Neuropediatrics 25:238-244
53. Melis D, Parenti G, Della Casa R et al (2004) Brain damage in glycogen storage disease type I. J Pediatr 144:637-642
54. Gutschalk A, Harting I, Cantz M, Springer C, Rohrschneider K, Meinck HM (2004) Adult alpha-mannosidosis: Clinical progression in the absence of demyelination. Neurology 63:1744-1746
55. Patlas M, Shapira MY, Nagler A, Sheffer R, Gomori JM (2001) MRI of mannosidosis. Neuroradiology 43:941-943
56. Dietemann JL, Filippi de la Palavesa MM, Tranchant C, Kastler B (1990) MR findings in mannosidosis. Neuroradiology 32:485-487
57. Galluzzi P, Rufa A, Balestri P, Cerase A, Federico A (2001) MR brain imaging of fucosidosis type I. AJNR Am J Neuroradiol 22:777-780
58. Ismail EA, Rudwan M, Shafik MH (1999) Fucosidosis: Immunological studies and chronological neuroradiological changes. Acta Paediatr 88:224-227
59. Terespolsky D, Clarke JT, Blaser SI (1006) Evolution of the neuroimaging changes in fucosidosis type II. J Inherit Metab Dis 19:775-781
60. Provenzale JM, Barboriak DP, Sims K (1995) Neuroradiologic findings in fucosidosis, a rare lysosomal storage disease. AJNR Am J Neuroradiol 16:809-813
61. Confort-Goyny S, Chabrol B, Vion-Dury J, Mancini J, Cozzone PJ (1993) MRI and localized proton MRS in early infantile form of neuronal ceroid-lipofuscinosis. Pediatr Neurol 9:57-60
62. Matheus MG, Castillo M, Smith JK, Armao D, Towle D, Muenzer J (2004) Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 46:666-672
63. Gabrielli O, Polonara G, Regnicolo L, Petroni V, Scarabino T, Coppa GV, Salvolini U (2004) Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses. Am J Med Genet 125:224-231
64. Barone R, Parano E, Trifiletti RR, Fiumara A, Pavone P (2002) White matter changes mimicking a leukodystrophy in a patient with mucopolysaccharidosis: A characterization by MRI. J Neurol Sci 195:171-175
65. Barone R, Nigro F, Triulzi F, Musumeci S, Fiumara A, Pavone L (1999) Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome). Neuropediatrics 30:270-274
66. Hughes DG, Chadderton RD, Cowie RA, Wraith JE, Jenkins JP (1997) MRI of the brain and craniocervical junction in Morquio's disease. Neuroradiology 39:381-385
67. Zafeiriou DI, Savvopoulou Augoustidou PA, Sewell A et al (2001) Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo's syndrome B). Brain Dev 23:385-389
68. Petitti N, Holder CA, Williams DW 3rd (1997) Mucopolysaccharidosis III (San Filippo syndrome) type B: Cranial imaging in two cases. J Comput Assist Tomogr 21:897-899
69. Shinomiya N, Nagayama T, Fujioka Y, Aoki T (1996) MRI in the mild type of mucopolysaccharidosis II (Hunter's syndrome). Neuroradiology 38:483-485
70. Lee C, Dineen TE, Brack M, Kirsch JE, Runge VM (1994) The mucopolysaccharidoses: Characterization by cranial MR imaging. AJNR Am J Neuroradiol 14:1285-1292
71. Parsons VJ, Hughes DG, Wraith JE (1996) Magnetic resonance imaging of the brain, neck and cervical spine in mild Hunter's syndrome (mucopolysaccharidoses type II). Clin Radiol 51:719-723
72. Buyukgebiz B, Eroglu Y, Kovanlikaya I, Sen A, Buyukgebiz A (1995) Maroteaux-Lamy syndrome associated with growth hormone deficiency. J Pediatr Endocrinol Metab 8:305-307
73. Murata R, Nakajima S, Tanaka A, Miyagi N, Matsuoka O, Kogame S, Inoue Y (1989) MR imaging of the brain in patients with mucopolysaccharidosis. AJNR Am J Neuroradiol 10:1165-1170
74. Gabrielli O, Salvolini U, Maricotti M, Mariani MG, Coppa GV, Giorgi PL (1992) Cerebral MRI in two brothers with mucopolysaccharidosis type 1 and different genotypes. Neuroradiology 34:313-315
75. Shimoda-Matsubayashi S, Kuru Y, Sumie H, Ito T, Hattori N, Okuma Y, Mizuno Y (1990) MRI findings in the mild type of mucopolysaccharidosis II (Hunter's syndrome). Neuroradiology 32:328-330
76. Rauch RA, Friloux LA 3rd, Lott I (1989) MR imaging of cavitary lesions in the brain with Hurler/Scheie. AJNR Am J Neuroradiol 10 (5 Suppl):S1-S3
77. Lee CC, Chen CY, Chou TY, Chen FH, Lee CC, Zimmerman RA (1996) Cerebral manifestations of Pompe disease in an infant. AJNR Am J Neuroradiol 17:321-322
78. Al-Essa MA, Bakheet SM, Patay ZJ, Powe JE, Ozand PT (1999) Normal fluorine-18-labelled 2-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging of the brain in Wolman disease. J Inherit Metab Dis 22:846-848
79. Yang YL, Sun F, Zhang Y et al (2006) Clinical and laboratory survey of 65 Chinese patients with Leigh syndrome. Chin Med J 118:373-377
80. Mannan AA, Sharma MC, Shrivastava P et al (2004) Leigh's syndrome. Indian J Pediatr 71:1029-1033
81. Crimi M, Papadimitriou A, Galbiati S et al (2004) A new mitochondrial DNA mutation in ND3 gene causing severe Leigh syndrome with early lethality. Pediatr Res 55:842-846
82. Filiano JJ, Goldenthal MJ, Mamourian AC, Hall CC, Marin-Garcia J (2002) Mitochondrial DNA depletion in Leigh syndrome. Pediatr Neurol 26:239-242
83. Cacic M, Wilichowski E, Mejaski-Bosnjak V et al (2001) Cytochrome c oxidase partial deficiency-associated Leigh disease presenting as an extrapyramidal syndrome. J Child Neurol 16:616-619
84. Nagashima T, Mori M, Katayama K et al (1999) Adult Leigh syndrome with mitochondrial DNA mutation at 8993. Acta Neuropathol (Berl) 97:416-422
85. Chu BC, Terae S, Takahashi C et al (1999) MRI of the brain in the Kearns-Sayre syndrome: Report of four cases and a review. Neuroradiology 41:759-764
86. Nakagawa E, Hirano S, Yamanouchi H, Goto Y, Nonaka I, Takashima S (1994) Progressive brainstem and white matter lesions in Kearns-Sayre syndrome: a case report. Brain Dev 16:416-418
87. Kim IO, Kim JH, Kim WS, Hwang YS, Yeon KM, Han MC (1996) Mitochondrial myopathy-encephalopathy-lactic acidosis-and strokelike episodes (MELAS) syndrome: CT and MR findings in seven children. AJR Am J Roentgenol 166:641-645
88. Wray SH, Provenzale JM, Johns DR, Thulborn KR (1995) MR of the brain in mitochondrial myopathy. AJNR Am J Neuroradiol 16:1167-1173
89. Nolli M, Barbieri A, Pinna C, Pasetto A, Nicosia F (2005) Wernicke's encephalopathy in a malnourished surgical patient: Clinical features and magnetic resonance imaging. Acta Anaesthesiol 49:1566-1570
90. Weidauer S, Nichtweiss M, Lanfermann H, Zanella FE (2003) Wernicke encephalopathy: MR findings and clinical presentation. Eur Radiol 13:1001-1009
91. Oka M, Terae S, Kobayashi R et al (2001) Diffusion-weighted MR findings in a reversible case of acute Wernicke encephalopathy. Acta Neurol Scand 104:178-181
92. Antunez E, Estruch R, Cardenal C, Nicolas JM, Fernandez-Sola J, Urbano-Marquez A (1998) Usefulness of CT and MR imaging in the diagnosis of acute Wenicke's encephalopathy. AJR Am J Roentgenol 171:1131-1137
93. Hahn JS, Berquist W, Alcorn DM, Chamberlain L, Bass D (1998) Wernicke encephalopathy and beriberi during total parenteral nutrition attributable to multivitamin infusion shortage. Pediatrics 101:E10
94. Huang CC, Chu NS, Yen TC, Wai YY, Lu CS (2003) Dopamine transporter binding in Wilson's disease. Can J Neurol Sci 30:163-167
95. Wu JC, Huang CC, Jeng LB, Chu NS (2000) Correlation of neurological manifestations and MR images in a patient with Wilson's disease after liver transplantation. Acta Neurol Scand 102:134-139
96. Alanen A, Komu M, Penttinen M, Leino R (1999) Magnetic resonance imaging and proton spectroscopy in Wilson's disease. Br J Radiol 72:749-756
97. Takahashi W, Yoshii F, Shinohara Y (1996) Reversible magnetic resonance imaging lesions in Wilson's disease: Clinical-anatomical correlation. J Neuroimaging 6:246-248
98. Huang CC, Chu NS (1998) Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease. Eur Neurol 39:32-37
99. Sener RN (1993) Wilson's disease: MRI demonstration of cavitations in basal ganglia and thalami. Pediatr Radiol 23:157
100. Saatci I, Topcu M, Baltaoglu FF, Kose G, Yalaz K, Renda Y, Besim A (1997) Cranial MR findings in Wilson's disease. Acta Radiol 38:250-258
101. Huang CC, Chu NS (1996) Wilson's disease: Resolution of MRI lesions following long-term oral zinc therapy. Acta Neurol Scand 93:215-218
102. Binesh N, Huda A, Thomas MA et al (2006) Hepatic encephalopathy: A neurochemical, and neurophysiological study. J Appl Clin Med Phys 7:86-96
103. Miyaoka T, Yasukawa R, Mihara T et al (2005) Fluid-attenuated inversion-recovery MR imaging in schizophrenia-associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). Eur Psychiatry 20:327-331
104. Yilmaz Y, Ekinci G (2002) Thalamic involvement in a patient with kernikterus. Eur Radiol 12:1837-1839
105. Ozdoba C, Pfenninger J, Schroth G (1997) Initial and follow-up MRI in a case of early diagnosed Reye's syndrome. Neuroradiology 39:495-498
106. Hoon AH Jr, Reinhardt EM, Kelley RI, Breiter SN, Morton DH, Naidu SB, Johnston MV (1997) Brain magnetic resonance imaging in suspected extrapyramidal cerebral palsy: Observations in distinguishing genetic-metabolic from acquired causes. J Pediatr 131:240-245
107. Schonberger S, Schweiger B, Schwahn B, Schwarz M, Wendel U (2004) Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82:69-75
108. Majoie CB, Mourmans JM, Akkerman EM, Duran M, Poll-The BT (2004) Neonatal citrullemia: Comparison of conventional MR, diffusion-weighted, and diffusion tensor findings. AJNR Am J Neuroradiol 25:32-35
109. Takei Y, Akahane C, Ikeda S (2003) Osmotic demyelination syndrome: reversible MRI findings in bilateral cortical lesions. Intern Med 42:867-870
110. Bourgouin P, Chalk C, Richardson J, Duong H, Vezina J (1995) Subcortical white matter lesions in osmotic demyelination syndrome. AJNR Am J Neuroradiol 16:1495-1497
111. Weber U, Huppe T, Niehaus L (2000) CT and MRI in severe hypophosphataemia with central nervous system involvement. Neuroradiology 42:112-114
112. Porto L, Lanferman H, Moller-Hartmann W, Jacobi G, Zanella F (1999) Acute necrotising encephalopathy of childhood after exanthema subitum outside Japan or Taiwan. Neuroradiology 41:732-734
113. Neilson DE, Eiben RM, Waniewski S et al (2003) Autosomal dominant acute necrotizing encephalopathy. Neurology 61:226-230
114. Hartfield DS, Loewy JA, Yager JY (1999) Transient thalamic changes on MRI in a child with hypernatremia. Pediatr Neurol 20:60-62
115. Kobari M, Nogawa S, Sugimoto Y, Fukuuchi Y (1997) Familial idiopathic brain calcification with autosomal dominant inheritance. Neurology 48:645-649
116. Nishio H, Kodama S, Matsuo T, Ichihashi M, Ito H, Fujiwara Y (1988) Cockayne syndrome: Magnetic resonance images of the brain in a severe form with early onset. J Inherit Metab Dis 11:88-102
117. Rabi II, Zacharias JR, Millman S, Kusch P (1938) A new method of measuring nuclear magnetic moment. Phys Rev 53:318
118. Solomon I (1955) Relaxation processes in a system of two spins. Phys Rev 99:559-565
119. Bloembergen N, Purcell EM, Pound RV (1948) Relaxation effects in nuclear magnetic resonance absorption. Phys Rev 73:679-712
120. Cavanagh J, Fairbrother WJ, Palmer AG III, Skelton NJ (1996) Protein NMR spectroscopy: Principles and practice. Academic Press, London, p 587
121. Holmberg V, Lauronen L, Autti T, Santavuori P, Savukoski M, Uvebrant P, Hofman I, Peltonen L, Jarvela I (2000) Phenotype-genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5). Neurology 55:579-581